Skip to Content

Robitussin Cough & Allergy FDA Alerts

The FDA Alert(s) below may be specifically about Robitussin Cough & Allergy or relate to a group or class of drugs which include Robitussin Cough & Allergy (chlorpheniramine/dextromethorphan/phenylephrine).

MedWatch Safety Alerts are distributed by the FDA and published by Following is a list of possible medication recalls, market withdrawals, alerts and warnings. For the latest FDA MedWatch alerts, go here.

Recent FDA Alert(s) for chlorpheniramine/dextromethorphan/phenylephrine


May 23, 2005

Audience: Healthcare professionals and consumers

FDA issued a Talk Paper to notify the public about the abuse of dextromethorphan (DXM), an ingredient found in many over-the-counter (OTC) cough and cold remedies. The agency is working with other health and law enforcement authorities to address this serious issue and warn the public of potential harm, after five recently reported deaths of teenagers that may be associated with the consumption of powdered DXM sold in capsules.

[May 20, 2005 - Talk Paper - FDA]

More Robitussin Cough & Allergy Resources